Home › Trial NCT03274011
Efficacy and Safety of Apatinib for Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
- Trial IDNCT03274011
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorFudan University
- Enrollment40
- Start date2017-07-01
- ConditionsEsophageal Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.